Aberdeen Group
MEDP icon

Aberdeen Group’s Medpace MEDP Stock Holding History

Aberdeen Group’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.6M Hold
42,748
– – 0.03% 409
2026
Q1 		$20.5M Hold
42,748
– – 0.03% 418
2025
Q4 		$24M Buy
42,748
+94
+0.2% +$53.4K 0.04% 368
2025
Q3 		$21.9M Buy
42,654
+98
+0.2% +$42.8K 0.03% 402
2025
Q2 		$13.4M Sell
42,556
-21,553
-34% -$6.47M 0.02% 531
2025
Q1 		$19.5M Sell
64,109
-745
-1% -$251K 0.04% 393
2024
Q4 		$21.5M Sell
64,854
-18,597
-22% -$6.31M 0.04% 351
2024
Q3 		$27.9M Sell
83,451
-3,684
-4% -$1.4M 0.05% 315
2024
Q2 		$35.9M Sell
87,135
-396
-0.5% -$157K 0.07% 264
2024
Q1 		$35.4M Buy
87,531
+70,048
+401% +$24.6M 0.07% 264
2023
Q4 		$5.36M Buy
+17,483
New +$4.72M 0.01% 656
2022
Q2 		– Sell
-8,000
Closed -$1.31M – 969
2022
Q1 		$1.31M Sell
8,000
-83
-1% -$13.7K ﹤0.01% 792
2021
Q4 		$1.76M Sell
8,083
-247,203
-97% -$51.8M ﹤0.01% 800
2021
Q3 		$48.3M Sell
255,286
-25,105
-9% -$4.58M 0.11% 191
2021
Q2 		$49.6M Sell
280,391
-99,993
-26% -$17.3M 0.11% 185
2021
Q1 		$62.4M Buy
380,384
+188,906
+99% +$28.9M 0.14% 151
2020
Q4 		$26.7M Buy
+191,478
New +$24.1M 0.07% 261

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Aberdeen Group's MEDP Position: Q2 2026 in Review

Aberdeen Group held its Medpace (MEDP) position steady in Q2 2026 at 42,748 shares worth $22.6M. The position accounts for 0.03% of the portfolio, ranked #409.

Aberdeen Group first reported a position in MEDP in Q4 2020 and has held it in 17 quarters since. The position peaked at $62.4M in Q1 2021. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Aberdeen Group held 42,748 shares of Medpace worth $22.6M as of Q2 2026.
  • Aberdeen Group left its Medpace share count unchanged in Q2 2026.
  • Medpace made up 0.03% of Aberdeen Group's portfolio in Q2 2026, its #409 holding.
  • Aberdeen Group first reported a position in Medpace in Q4 2020 and has held it in 17 quarters since.
  • Aberdeen Group's Medpace position peaked at $62.4M in Q1 2021.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.